Novartis Pharmaceuticals Director of Engineering Salaries in Warner Robins, GA
The average Novartis Pharmaceuticals Director of Engineering in Warner Robins, GA earns an estimated $219,842 annually, which includes an estimated base salary of $177,918 with a $41,923 bonus. Novartis Pharmaceuticals' Director of Engineering compensation is $32,460 more than the US average for a Director of Engineering. Director of Engineering salaries at Novartis Pharmaceuticals in Warner Robins, GA can range from $94,000 - $473,000.
In Warner Robins, GA, The Engineering Department at Novartis Pharmaceuticals earns $12,997 more on average than the Sales Department.
Last updated 2 years ago.
- $177,918
- avg. base
- $41,923
- avg. bonus
Director of Engineering Salaries at Novartis Pharmaceuticals
In Warner Robins, GA, Directors of Engineering earn $4,994 more than Directors of Engineering.
Compensation at Novartis Pharmaceuticals by Department
In Warner Robins, GA, The Engineering Department averages $12,997 more than the Sales Department, and $10,948 less than the Product Department
Director of Engineering Compensation by Gender (All Companies)
The average female Director of Engineering at companies similar size to Novartis Pharmaceuticals reported making $233,006, while the average male Director of Engineering at similar sized companies reported making $235,035.
Director of Engineering Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Director of Engineering at companies similar size to Novartis Pharmaceuticals reported making $247,783, while the average Native American Director of Engineering at similar sized companies reported making $150,000.
How Directors of Engineering at Novartis Pharmaceuticals Rate Their Compensation
The majority of Directors of Engineering at Novartis Pharmaceuticals believe they're compensated fairly. 100% of Directors of Engineering at Novartis Pharmaceuticals say they receive annual bonuses, and the vast majority (79%) are satisfied with their benefits. See more compensation ratings at Novartis Pharmaceuticals
